Attenuation of WNT/Β-Catenin Signaling in Patients With Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

International Journal of Biological Sciences - Canada
doi 10.7150/ijbs.32331
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ivyspring International Publisher

Related search

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

JAMA Dermatology
DermatologyMedicine
2015English

Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis Associated With Zonisamide

Clinical Case Reports
Medicine
2017English

New Insights in Stevens Johnson Syndrome/ Toxic Epidermal Necrolysis Syndrome

Clinical and Translational Allergy
ImmunologyPulmonaryAllergyRespiratory Medicine
2014English

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Oncologic Considerations

Clinical Journal of Oncology Nursing
Oncology
2004English

The Current Understanding of Stevens–Johnson Syndrome and Toxic Epidermal Necrolysis

Expert Review of Clinical Immunology
AllergyImmunology
2011English

Pediatric Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the United States

Journal of the American Academy of Dermatology
Dermatology
2017English

Analisis Cost of Illness Stevens Johnson Syndrome (SJS)/Toxic Epidermal Necrolysis (TEN)

Jurnal Pharmascience
2020English

Readmission Risk Factors and Complications in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis

Cureus
2020English

Reply To: “Prognosis and Management of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis”

Journal of the American Academy of Dermatology
Dermatology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy